射血分数保留的心力衰竭伴正常利钠肽水平与发病率和死亡率增加相关
比较HFpEF伴正常NP(NT-proBNP<125 ng/L,n=157)、HFpEF伴高NP(NT-proBNP≥125 ng/L,n=263)及血流动力学正常对照(n=161)。结果显示正常NP HFpEF患者运动时心输出量储备保留但左室跨壁压升高,校正年龄、性别和BMI后死亡或心衰再入院风险较对照高2.74倍(95%CI 1.02-7.32)。
要点
- HFpEF患者中相当比例NT-proBNP正常,仍存在舒张功能障碍和充盈压升高。
- 正常NP HFpEF运动心输出量储备保留,但需以更高的左室跨壁压为代价。
- 正常NP HFpEF死亡或心衰再入院风险仍较无HF对照高2.74倍。
核心结论
- HFpEF伴正常NP患者表现为轻度舒张功能障碍和运动时心输出量储备保留,尽管充盈压显著升高。
- 正常NP HFpEF临床结局虽不及高NP HFpEF差,但死亡或心衰再入院风险仍高于无HF对照。
研究设计与样本
- HFpEF定义为静息PAWP≥15 mmHg或运动PAWP≥25 mmHg。
- 正常NP组n=157(NT-proBNP<125 ng/L),高NP组n=263(NT-proBNP≥125 ng/L),对照组n=161(血流动力学正常)。
主要发现
- 正常NP HFpEF较高NP HFpEF年轻,但较对照年长,合并症谱居中。
- 正常NP HFpEF较对照有更多左室肥厚和更差舒张功能,但较高NP HFpEF舒张功能更好、左房容积更低、右室功能更优、二尖瓣/三尖瓣反流更少。
- 正常NP HFpEF运动心输出量储备为预计值101%(IQR 75-124%),左室跨壁压14±6 mmHg,高于对照的7±4 mmHg(P<0.001)。
- 高NP HFpEF运动心输出量储备为预计值85%(IQR 59-109%),左室跨壁压10±8 mmHg,低于正常NP HFpEF(P<0.001),尽管PAWP相似。
- 校正年龄、性别和BMI后,正常NP HFpEF死亡或心衰再入院风险较对照高2.74倍(HR 2.74,95%CI 1.02-7.32)。
关键数值与推荐
- HFpEF定义:静息PAWP≥15 mmHg或运动PAWP≥25 mmHg。
- 正常NP定义:NT-proBNP<125 ng/L;高NP定义:NT-proBNP≥125 ng/L。
临床怎么用
- 对不明原因呼吸困难患者,即使NT-proBNP正常,也应考虑HFpEF可能并评估充盈压。
- 正常NP HFpEF患者仍需关注死亡和心衰再入院风险,不应因NP正常而低估预后。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: A substantial proportion of patients with heart failure (HF) with preserved ejection fraction (HFpEF) present with normal natriuretic peptide (NP) levels. The pathophysiology and natural history for this phenotype remain unclear. METHODS AND RESULTS: Consecutive subjects undergoing invasive cardiopulmonary exercise testing for unexplained dyspnoea at Mayo Clinic in 2006-18 were studied. Heart failure with preserved ejection fraction was defined as a pulmonary arterial wedge pressure (PAWP) ≥15 mmHg (rest) or ≥25 mmHg (exercise). Patients with HFpEF and normal NP [N-terminal of the pro-hormone B-type natriuretic peptide (NT-proBNP) < 125 ng/L] were compared with HFpEF with high NP (NT-proBNP ≥ 125 ng/L) and controls with normal haemodynamics. Patients with HFpEF and normal (n = 157) vs. high NP (n = 263) were younger, yet older than controls (n = 161), with an intermediate comorbidity profile. Normal NP HFpEF was associated with more left ventricular hypertrophy and worse diastolic function compared with controls, but better diastolic function, lower left atrial volumes, superior right ventricular function, and less mitral/tricuspid regurgitation compared with high NP HFpEF. Cardiac output (CO) reserve with exercise was preserved in normal NP HFpEF [101% predicted, interquartile range (IQR): 75-124%], but this was achieved only at the cost of higher left ventricular transmural pressure (LVTMP) (14 ± 6 mmHg vs. 7 ± 4 mmHg in controls, P < 0.001). In contrast, CO reserve was decreased in high NP HFpEF (85% predicted, IQR: 59-109%), with lower LVTMP (10 ± 8 mmHg) compared with normal NP HFpEF (P < 0.001), despite similar PAWP. Patients with high NP HFpEF displayed the highest event rates, but normal NP HFpEF still had 2.7-fold higher risk for mortality or HF readmissions compared with controls (hazard ratio: 2.74, 95% confidence interval: 1.02-7.32) after adjusting for age, sex, and body mass index. CONCLUSION: Patients with HFpEF and normal NP display mild diastolic dysfunction and preserved CO reserve during exercise, despite marked elevation in filling pressures. While clinical outcomes are not as poor compared with patients with high NP, patients with normal NP HFpEF exhibit increased risk of death or HF readmissions compared with patients without HF, emphasizing the importance of this phenotype.
引用
- Verbrugge, Omote, Reddy, et al. Heart failure with preserved ejection fraction in patients with normal natriuretic peptide levels is associated with increased morbidity and mortality. Eur Heart J. 2022. PMID: 35139159. doi:10.1093/eurheartj/ehab911
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。